Surgically resected cystic lesions in the sellar-suprasellar region: Value of qualitative, semiquantitative, and quantitative imaging variables in the diagnostic work-up
IF 3.3 3区 医学Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
R. Calandrelli , A. Grimaldi , S. Chiloiro , S.A. De Sanctis , A.G. Castelli , P. Mattogno , M. Gessi , F. Doglietto
{"title":"Surgically resected cystic lesions in the sellar-suprasellar region: Value of qualitative, semiquantitative, and quantitative imaging variables in the diagnostic work-up","authors":"R. Calandrelli , A. Grimaldi , S. Chiloiro , S.A. De Sanctis , A.G. Castelli , P. Mattogno , M. Gessi , F. Doglietto","doi":"10.1016/j.ejrad.2025.112429","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To identify reliable imaging variables for differentiating cystic lesions by integrating qualitative, semiquantitative, and quantitative features.</div></div><div><h3>Materials & Methods</h3><div>A retrospective analysis of 100 histologically confirmed cystic sellar-suprasellar lesions was performed using preoperative CT and MRI. Qualitative (topography, type, shape, intracystic components, edema, calcifications), semiquantitative (wall thickness), and quantitative (intracystic signal intensity from T2- and pre-contrast T1-weighted MRI) features were assessed. Multivariable models were developed by combining the most reliable imaging variables specific to each cystic lesion category.</div></div><div><h3>Results</h3><div>Lesions were categorized as Rathke’s cysts (RCC, 39), papillary (PCP, 14) and adamantinomatous craniopharyngiomas (ACP, 21), pituitary neuroendocrine tumors (PitNets, 18), arachnoid cysts (AC, 8). No clinical presentation was pathognomonic. Multivariable models showed high diagnostic accuracy: 82 % for RCC identifying wall thickness < 1 mm (OR 7.160, p = 0.009) and low T2<sub>min</sub> (OR 1.043, p = 0.006) as key predictors; 89 % for PCP despite the absence of distinct independent predictors; 89 % for ACP with parietal calcifications identified as the strongest predictor (OR 0.043, p < 0.001); 90 % for PitNets identifying wall thickness > 2 mm as the strongest predictor (OR 0.52, p < 0.001); and 97 % for AC identifying wall thickness < 1 mm (OR 10.983, p = 0.019) and high T2<sub>min</sub> (OR 0.947, p = 0.039) as key predictors.</div></div><div><h3>Conclusion</h3><div>No single variable was sufficient for diagnosis but integrating specific and sensitive imaging features improved cystic lesion differentiation, aiding accurate diagnosis and management.</div></div>","PeriodicalId":12063,"journal":{"name":"European Journal of Radiology","volume":"193 ","pages":"Article 112429"},"PeriodicalIF":3.3000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Radiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0720048X25005157","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
To identify reliable imaging variables for differentiating cystic lesions by integrating qualitative, semiquantitative, and quantitative features.
Materials & Methods
A retrospective analysis of 100 histologically confirmed cystic sellar-suprasellar lesions was performed using preoperative CT and MRI. Qualitative (topography, type, shape, intracystic components, edema, calcifications), semiquantitative (wall thickness), and quantitative (intracystic signal intensity from T2- and pre-contrast T1-weighted MRI) features were assessed. Multivariable models were developed by combining the most reliable imaging variables specific to each cystic lesion category.
Results
Lesions were categorized as Rathke’s cysts (RCC, 39), papillary (PCP, 14) and adamantinomatous craniopharyngiomas (ACP, 21), pituitary neuroendocrine tumors (PitNets, 18), arachnoid cysts (AC, 8). No clinical presentation was pathognomonic. Multivariable models showed high diagnostic accuracy: 82 % for RCC identifying wall thickness < 1 mm (OR 7.160, p = 0.009) and low T2min (OR 1.043, p = 0.006) as key predictors; 89 % for PCP despite the absence of distinct independent predictors; 89 % for ACP with parietal calcifications identified as the strongest predictor (OR 0.043, p < 0.001); 90 % for PitNets identifying wall thickness > 2 mm as the strongest predictor (OR 0.52, p < 0.001); and 97 % for AC identifying wall thickness < 1 mm (OR 10.983, p = 0.019) and high T2min (OR 0.947, p = 0.039) as key predictors.
Conclusion
No single variable was sufficient for diagnosis but integrating specific and sensitive imaging features improved cystic lesion differentiation, aiding accurate diagnosis and management.
目的综合定性、半定量和定量特征,寻找鉴别囊性病变的可靠影像学指标。方法对100例经组织学证实的鞍上囊性病变进行术前CT和MRI回顾性分析。定性(地形、类型、形状、囊内成分、水肿、钙化)、半定量(壁厚)和定量(T2和对比前t1加权MRI的囊内信号强度)特征进行评估。多变量模型是通过结合针对每种囊性病变类别的最可靠的成像变量而建立的。结果病变分为Rathke囊肿(RCC, 39例)、乳头状瘤(PCP, 14例)、硬瘤性颅咽管瘤(ACP, 21例)、垂体神经内分泌肿瘤(PitNets, 18例)、蛛网膜囊肿(AC, 8例)。没有临床表现是典型的。多变量模型显示出较高的诊断准确率:82%的RCC将壁厚<; 1 mm (OR 7.160, p = 0.009)和低T2min (OR 1.043, p = 0.006)作为关键预测因子;89%为PCP,尽管没有明显的独立预测因子;89%的ACP合并顶骨钙化被认为是最强的预测因子(OR 0.043, p < 0.001);90%的PitNets认为壁厚2mm是最强的预测因子(OR 0.52, p < 0.001);97%的AC认为壁厚<; 1 mm (OR 10.983, p = 0.019)和高T2min (OR 0.947, p = 0.039)是关键预测因子。结论囊性病变的单一诊断指标并不充分,综合特异、敏感的影像学特征可提高囊性病变的鉴别水平,有助于准确诊断和治疗。
期刊介绍:
European Journal of Radiology is an international journal which aims to communicate to its readers, state-of-the-art information on imaging developments in the form of high quality original research articles and timely reviews on current developments in the field.
Its audience includes clinicians at all levels of training including radiology trainees, newly qualified imaging specialists and the experienced radiologist. Its aim is to inform efficient, appropriate and evidence-based imaging practice to the benefit of patients worldwide.